
China is a country with a high incidence of gastrointestinal tumors. According to clinical data, currently in China, early-stageGastric Cancer Detection RateLess than 20%.Early Screening, Early Diagnosis, and Early TreatmentIt is the most effective approach to fundamentally reduce gastric cancer mortality and lower treatment costs., undergoing a single endoscopic examination with polypectomy during the at-risk age period reduces the risk of developing cancer by 68%.
To enable large-scale populations to undergo early screening and diagnosis of gastric cancer,Guangzhou Side Medical Technology Co., Ltd.(hereinafter referred to as “Side Medical”) after 16 years of research and development“The World’s First Console-Free, Wearable-Free Capsule Endoscopy System for Stomach Examination via Smartphone, Scalable Across Diverse Scenarios”, the product successfully obtained the NMPA Class III Medical Device Registration Certificate (National Medical Device Registration No. 20243060443) in March 2024.As a one-stop solution for intragastric and gastrointestinal diseases, the mobile capsule gastroscope offers advantages such as being painless, non-invasive, anesthesia-free, and free from cross-infection.It provides new options and convenience for patients and physicians, offering improved suitability particularly for patients with poor adherence, those who cannot undergo anesthesia, those prone to mucosal bleeding, and those at high risk of transmission.
On Wednesday, September 25, at 19:30, the 97th session of VCBeat’s New Product Showcase will feature Wang Yunzhong, General Manager of Side Medical, and Zhang Fan, Marketing Director of Side Medical, who will present"The world's first capsule endoscope for gastric examination without a host device or wearable equipment"Product Promotion.
Capsule Gastric Endoscopy System GICE-1000 (Mobile Phone Capsule Gastroscope)
This system consists ofCapsule Gastroscopy、Portable Recorder、App Software、Image Analysis SoftwareComposition.
Operated via connection to a mobile app,After the user swallows the capsule, they guide its movement along a preset gastrointestinal tract by changing body positions. The camera continuously captures digital images of the stomach at a rate of 3 frames per second, synchronizing the footage to a mobile phone in real time throughout the procedure.。
Just 20 minutes, allowing for easy completion of intragastric examination and generation of a "gastric wall map" to illustrate the coverage of anatomical regions examined. A single examination captures5,000–8,000 sheetsGastric images are automatically uploaded to the intelligent image interpretation system,Approximately 15 minutesAutomatically generate examination reports and send them to your mobile phone.
New technologies are expected to facilitate large-scale early screening for gastric cancer in China. The system is projected to processOver 1,000 patient examinations, capable of meeting the annual demand forOver 150 million visitsexamination requirements, “Compared with electronic gastroscopy, this capsule endoscopy system for the stomach,”The diagnostic concordance rate reached 96.8%."In the next phase, the R&D teamIt is expected to achieve full gastrointestinal tract examination coverage, including the esophagus, stomach, small intestine, and colorectum, by 2028.。
In addition, the company has established a partnership with large teaching hospitals.Data Center and Kanghua Cloud Mirror Imaging Center, enabling self-assessment and screening of gastric health risks in large populations, with a cloud-based high-efficiency image interpretation systemCapable of handling an annual examination volume of 150 million cases, providing a precise, convenient, and universally accessible one-stop innovative solution for the screening and early diagnosis of major gastrointestinal diseases.
Scan the QR code on the poster to add our assistant and reserve your spot for the live broadcast.


Wang Yunzhong
General Manager, Side Medical
Senior Professional Manager, specializing in industrial transformation and resource integration, dedicated to advancing the cutting-edge technological development of China's healthcare industry.

Zhang Fan
Marketing Director, Side Medical
With 20 years of experience in medical marketing management, successfully spearheaded the end-to-end launch and commercialization of multiple medical products from inception to market. Possesses deep expertise in the marketing of capsule endoscopy, with profound insights into the ecosystem of China’s capsule endoscopy industry, and excels in formulating innovative channel promotion strategies.
About Side Medical
Guangzhou Side Medical Technology Co., Ltd. (hereinafter referred to as “Side Medical”) is a high-tech enterprise specializing in the research and development, manufacturing, and sales of medical devices in the field of gastroenterology. Established in 2019, the company was founded by a renowned gastroenterology expert in China who receives special government allowances from the State Council for his contributions to capsule endoscopy. Headquartered on Guangzhou International Bio Island in Huangpu District, Side Medical has successfully completed its Series A financing round led by prominent investors, laying a solid foundation for its rapid growth.
The company has successfully developed the world’s first smartphone-based capsule gastroscopy system that operates without a main console or wearable devices, enabling large-scale, multi-scenario applications in the future. The company has established a Capsule Endoscopy Image Reading Center, which not only provides image interpretation services for Sidea’s smartphone gastroscope but also offers third-party reading services. It professionally delivers remote diagnostic services for gastric diseases based on the “Internet Plus” model, facilitating self-testing and screening of gastric health risks across large populations. Its cloud-based high-efficiency image reading system aims to achieve an annual capacity of 150 million examinations, striving to provide inclusive and accessible comprehensive solutions for early detection and screening of major gastrointestinal diseases for the global population of 8 billion.
The company has been recognized as a National High-Tech Enterprise and a Guangdong Province “Specialized, Refined, Differential, and Innovative” SME. It has participated in key national initiatives, including the Ministry of Industry and Information Technology’s “Open Competition” program for AI medical device innovation, and the Guangdong Provincial Key Areas R&D Program. To date, the company has secured 55 patents, 4 software copyrights, and 40 trademarks.
About VCBeat's New Product Launch
“VCBeat New Product Showcase” is a live-streaming series dedicated to supporting the launch of innovative products by healthcare companies. The series’ mission is to facilitate the milestone release of every innovative medical product. If your company has plans to launch an innovative medical product or achieve a significant milestone and wishes to participate in the “VCBeat New Product Showcase,” please add our assistant for consultation.
Method 1: Watch the live stream via the mini-program
Scan the QR code below to contact the assistant and schedule a live stream (if already added, please proactively reach out to the assistant).

Option 2: Watch the live stream on the VCBeat app for a chance to win exciting prizes
Scan the QR code below to download the VCBeat app and register to watch the live stream.

Send a screenshot of the live stream to the assistant to enter the lucky draw for a chance to win a [15-day trial membership of VBInsight Industry Think Tank].
